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Abstract
Background: The reticulon Nogo-B participates in cellular and immunological processes in murine macrophages.
Since leukocytes are an essential part of the immune system in health and disease, we decided to investigate the
expression of Nogo-A, Nogo-B and Nogo-C in different human immune cell subpopulations. Furthermore, we
analyzed the localization of Nogo-B in human monocyte-derived macrophages by indirect immunofluorescence
stainings to gain further insight into its possible function.
Findings: We describe an association of Nogo-B with cytoskeletal structures and the base of filopodia, but not
with focal or podosomal adhesion sites of monocyte-derived macrophages. Nogo-B positive structures are partially
co-localized with RhoA staining and Rac1 positive membrane ruffles. Furthermore, Nogo-B is associated with the
tubulin network, but not accumulated in the Golgi region. Although Nogo-B is present in the endoplasmic
reticulum, it can also be translocated to large cell protrusions or the trailing end of migratory cells, where it is
homogenously distributed.
Conclusions: Two different Nogo-B staining patterns can be distinguished in macrophages: firstly we observed
ER-independent Nogo-B localization in cell protrusions and at the trailing end of migrating cells. Secondly, the
localization of Nogo-B in actin/RhoA/Rac1 positive regions supports an influence on cytoskeletal organization. To
our knowledge this is the first report on Nogo-B expression at the base of filopodia, thus providing further insight
into the distribution of this protein.
1. Background
Reticulons (RTN) are ancient proteins mainly residing
in the endoplasmic reticulum (ER) with diverse con-
served physiological functions in membrane trafficking,
apoptosis and cytoskeletal rearrangements/adhesion
[1-6] as well as gain of function in certain tissues [7].
RTN4A/Nogo-A is the largest isoform encoded by the
rtn4/nogo gene, which also gives rise to RTN4B/Nogo-B
and RTN4C/Nogo-C [8,9]. Nogo-A is mainly expressed
in white-matter oligodendrocytes where it acts as a
neurite growth inhibitor [10] through interaction with
the Nogo receptor (NgR) and the paired immunoglobu-
lin-like receptor B (PirB) [11-13]. Nogo-C is found in
neurons and skeletal muscle [14,15]. Recently, much
attention is also drawn to the Nogo-B protein, the
Nogo-B receptor (NgBR) and interaction partners
[16-18]. Although Nogo-B is expressed ubiquitously, the
highest expression is found in endothelial cells, vascular
smooth muscle cells and inflammatory cells. In
endothelial and smooth muscle cells, Nogo-B is asso-
ciated with in vitro adhesion and promotion/inhibition
of chemotaxis [19]. It has been demonstrated that
Nogo-B knockout mice suffer from a lack of migrating
tissue macrophages to sites of ischemic vascular injury
and show slower wound healing [20]. Macrophages
lacking Nogo-B present themselves with impaired Rac
activation, spreading, migration, cytoskeletal organiza-
tion and reduced expression of inflammatory genes
upon stimulation. As leukocytes play an essential part
in immunology, we investigated the expression and
localization of Nogo-A, Nogo-B and Nogo-C in human
immune cell subpopulations.
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2. Results and discussion
2.1. Expression of Nogo splicing variants/isoforms in
different populations of human immune cells
The expression of Nogo splicing variants/isoforms was
analyzed in human monocytes (CD14+), T cells (CD3+)
and B cells (CD19+). In a first step, mRNA expression was
compared to the expression in human brain (Figure 1a).
The levels of Nogo-A were very low (0.2-0.5% of brain
expression), but present in all investigated cell populations.
These findings are in line with studies demonstrating the
role of Nogo-A in basic cellular functions, such as in shap-
ing the membrane of tubular ER [21-23]. Nogo-C could
only be detected in T cells (1.7-4.6% of brain expression),
confirming its predominant expression in skeletal muscle
and brain. In contrast, Nogo-B mRNA was strongly
expressed in all cell populations, reaching 72% (T cells),
76% (B cells) and 89% (monocytes) of the expression in
brain. This reflects its previously reported ubiquitous
expression pattern [8,14,19,24].
To show whether mRNA levels were reflected on the
protein level, western blots were performed. We detected
Nogo-A and Nogo-B protein levels corresponding to their
mRNA distribution pattern. Nogo-B presented itself with
one 45 KDa band in all immune cell populations and two
bands at 44 KDa and 45 KDa in human brain (Figure 1b),
whereas Nogo-A was detectable at 140 KDa (Figure 1c).
The molecular weights of human Nogo-A and Nogo-B
correspond well to previous reports [25,26].
2.2. Nogo-B localization in human monocyte-derived
macrophages depends on their morphology
In a next step, we analyzed the localization of Nogo-B in
human monocyte-derived macrophages. Nogo-B showed
different staining patterns depending on cell morphol-
ogy (Figure 2).
In round and quiescent cells, Nogo-B showed the
expected reticular staining pattern (Figure 2a) [Addi-
tional file 1]. However, towards elongated or activated
cell shapes, an elongate and/or punctate Nogo-B pattern
appeared in the cell periphery. Similar structures were
observed in phase contrast microscopy (Figure 2b).
Nogo-B positive, radial patterns in the cell periphery
were possibly associated with the polarization level of
the cell, showing a shift from widely spread distributions
(Figure 2c) to a more polarized localization in cells with
advanced elongation (Figure 2d). Finally, teardrop
shaped and polarized, migrating macrophages showed a
strong translocation of Nogo-B to the rear of the cell
with remnant reticular staining (Figure 2e). The obser-
vations presented here possibly represent a dynamic
change of Nogo-B localization during cytoskeletal
changes or polarization [27-31].
Figure 1 Nogo expression in human immune cell subpopulations. (a) Detection of high transcript levels of Nogo-B and very low levels of
Nogo-A in human T cells (CD3+), B cells (CD19+) and monocytes (CD14+) in relation to the expression in human brain (human brain is set to
the value of 1.0 on the y-axis). Only T cells express low levels of Nogo-C, whereas all Nogo splicing variants are highly expressed in human brain,
serving as calibrator. Data are shown as means and standard deviations of independent real-time PCR experiments using cDNAs obtained from
the respective immune cell populations of four different donors. (b) and (c) Representative Western Blots for the detection of Nogo-B and Nogo-
A proteins in human brain/immune cell subpopulations and attached controls for unspecific reactions of secondary antibody. The protein
distribution reflects the transcript level, with Nogo-B being present in all cell types and Nogo-A only showing signals in human brain at 140 KDa
(the specific target peptide rhNIG serves as positive control). Nogo-B shows either two bands at 44/45 KDa in human brain, or one band at
45 KDa in immune cell subpopulations. Although the antibody used in (b) should be able to detect Nogo-C and Nogo-A, no signals were
observed. Images shown are representative for independent experiments performed using the respective immune cell subpopulations of three
different donors.
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2.3. Nogo-B is associated with cytoskeletal structures and
Rho GTPases
Due to the observed staining patterns of Nogo-B shown
above, a possible association with cytoskeletal elements
might be postulated. Co-labeling with actin showed a
partial co-localization in the area of elongate and punc-
tate Nogo-B positive structures in the cell periphery
(Figure 3a), whereas vinculin showed no co-labeling. In
fact, vinculin positive focal/podosomal adhesion sites
were exclusively excluded from the Nogo-B staining
(Figure 3c). We propose that Nogo-B is possibly involved
in cytoskeletal rearrangements, but not directly asso-
ciated with adhesion sites. According to Yu et al [20],
murine Nogo knockout macrophages show less actin
expression and cell spreading than wildtype cells. In our
study, punctate Nogo-B stainings were regularly observed
at the base of long, thin, actin containing cell protrusions
(Figure 3b). However, this observation did not apply to
all such structures present on a cell (Figure 3a), possibly
distinguishing between filopodia and retraction fibers,
although the latter are often called filopodia in literature
[32]. Filopodia are generally thought to act as sensors in
exploring the extracellular matrix [33,34]. However, the
view on filopodia function has expanded recently [35,36].
Xue et al [37] demonstrated an influence of filopodia
development and presence on cell migration. Thus, the
observed effect of less spreading and migration in Nogo
knockout cells [20] may also be explained by its lack at
the base of filopodia and the resulting effect on the cytos-
keleton in general. Filopodia play an important role in
chemotaxis, cell-cell interaction and pathway activation
[38-41]. Therefore, the reduction of inflammatory cyto-
kines upon stimulation in Nogo knockout macrophages
observed by Yu et al [20] might also be explained by an
impaired function of filopodia.
Yu et al explain the effect of reduced spreading and
actin expression by showing low Rac activity in Nogo
knockout cells as well as co-localizations of Nogo and
Rac. As the actin remodeling factors Rac1 and RhoA
are in close cross-talk [42,43] we decided to analyze
their localizations in respect to Nogo-B. Therefore,
co-labelings were performed, showing a partial co-
localization with RhoA in elongate Nogo-B positive
structures (Figure 3d). Rac1, as well as RhoA positive
dorsal membrane ruffles were negative for Nogo-B
(Figure 3d and 3e) although Rac1 positive peripheral
membrane ruffles could be associated with Nogo-B
(Figure 3e), as described before [20].
Tubulin co-labeling showed a strong co-localization
with Nogo-B, supporting the observations by Rousseau
et al [44]. Interestingly, the association with tubulin van-
ished in the area of Nogo-B accumulations in membrane
protrusions (Figure 4a), indicating the detachment of
Nogo-B from tubulin.
Figure 2 Localization of Nogo-B in macrophages with different
morphology. Monocyte-derived macrophages showing different
morphologies and the respective Nogo-B staining pattern (left
panel). Structures similar to the staining pattern are visible in phase
contrast microscopy (right panel): (a) Quiescent, round cell with
reticular Nogo-B staining. (b) Activated cell with elongate and
mainly punctate Nogo-B positive areas in the periphery (arrows, see
inlay). (c) Radial, elongate Nogo-B staining patterns in the cell
periphery of an elongated cell (arrows, see inlay). Note the
unstructured Nogo-B accumulation in the left area of the cell. (d)
Polarized, longish Nogo-B structures in an elongated cell (arrows,
see inlay) (e) Strong Nogo-B translocation to the trailing end of
migrating macrophages (arrow) with remnant reticular staining. All
representative cell images are of one donor, showing comparable
staining patterns observed in independent cultures of six donors. All
images were acquired by conventional fluorescence microscopy
using a DMI 4000B microscope and Application Suite V3.1 by Leica
and represent cells cultured in 24-well cell culture plates.
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Figure 3 Nogo-B and cytoskeletal structures in monocyte-derived macrophages. (a) Partial co-localizations of Nogo-B and actin in punctate
and elongate peripheral cell structures (arrowheads) and at the base of filopodia (arrows) with enlarged detail in inlay. Note that Nogo-B is not
always present at the base of filopodia. (b) Nogo-B expression at the base of filopodia (see inlay). Actin stress fibers are not positive for Nogo-B.
(c) Nogo-B is excluded from focal and podosomal adhesion sites (see inlay) (d) Intracellular, longish staining patterns of Nogo-B partially co-
localize with RhoA (see inlay) (e) Nogo-B is present in Rac1 positive peripheral membrane ruffles (see inlay). Cells shown are representative of
regularly observed staining patterns/co-localizations in independent macrophage cultures of six different donors. All images were acquired by
conventional fluorescence microscopy using a DMI 4000B microscope and Application Suite V3.1 by Leica and represent cells cultured in 24-well
cell culture plates.
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Nogo-B is a reticulon and localizes to the ER. There-
fore, co-labelings with the ER residing protein calnexin
showed an expected co-localization with Nogo-B in the
cell center. However, no enriched calnexin signal was
observed in the peripheral areas of strong Nogo-B accu-
mulation (Figure 4b). This observation might be
explained by the predominant localization of calnexin to
rough ER [45], which is usually comprised of membrane
sheets [46]. Therefore, an association of Nogo-B with
tubular ER cannot be excluded in the Nogo-B enriched,
peripheral areas.
Additionally, Golgi stainings with the marker GM-130
were performed. A possible association with Nogo-B
could not be excluded, although Nogo-B does not seem
to be accumulated in the Golgi area (Figure 4c).
3. Conclusion
The role of Nogo-B in monocyte-derived macrophages
seems very diverse and challenging. In this study we
demonstrate that Nogo-B is always present in the ER but
can be translocated to large cell protrusions or the rear
of migratory cells, where detachment from tubulin seems
to take place. Additionally or independently, Nogo-B can
be found at the base of filopodia, but not at focal/podoso-
mal adhesion sites. Cells possibly undergoing polarization
or cytoskeletal rearrangements show a prominent pattern
of elongate or punctate Nogo-B positive areas in the
periphery. Partial co-labelings with actin and the Rho
GTPases RhoA and Rac1 support a direct or indirect
influence on the cytoskeletal regulation. Furthermore, the
finding of Nogo-B positivity at the base of filopodia may
Figure 4 Confocal imaging of Nogo-B and the tubulin network, endoplasmic reticulum and Golgi apparatus. (a) Shows the strong
association of Nogo-B with the tubulin network. Note the Nogo-B accumulation and detachment from tubulin in the cell protrusion. (b) Nogo-B
co-localizes with the endoplasmic reticulum in the cell center, whereas no enriched calnexin signal can be observed in peripheral areas of Nogo-
B accumulation. (c) Nogo-B shows a low presence in the Golgi apparatus compared to surrounding structures. All images are representative of
regularly observed staining patterns/co-localizations in independent macrophage cultures of six different donors. Cells were analyzed by confocal
laser scanning microscopy using an UltraVIEW RS (Perkin Elmer) mounted on an Olympus IX-70 inverse microscope. Images were acquired using
the UltraVIEW RS software (Perkin Elmer). Shown are z-stacks of 0.5 μm thickness.
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provide important information on these structures and
gives deeper insight into a protein, which has not been
associated in this context before.
4. Materials and methods
4.1. Isolation of peripheral blood mononuclear cells
(PBMC)
Anonymized blood samples from 10 different healthy
blood donors, which were not suitable for blood transfu-
sion, were obtained with informed consent from the
Central Institute for Blood Transfusion and Immunolo-
gical Department (Innsbruck University Hospital)
according to the ethical regulations of Innsbruck Uni-
versity Hospital. PBMC were isolated by density-gradi-
ent centrifugation, washed and resuspended in the
respective medium or buffer.
4.2. Positive selection of immune cell subpopulations
Isolation was performed according to the manufac-
turers’ instructions (BD Biosciences) using magnetic
beads labeled with anti-CD3, anti-CD19 or anti-CD14
antibodies. After isolation, cells were counted and
lysed with TRIZOL reagent (Invitrogen) or protein
lysis buffer (1% NP-40, 150 mM NaCl, 50 mM HEPES
pH 7.6, 0.8 mM MgCl2, 5 mM EGTA, protease
inhibitor cocktail by Roche Applied Science). Purity
assessed by flow cytometry was >89% in all cases (data
not shown).
4.3. Semi-quantitative real-time PCR
RNA was extracted from the respective immune cell
populations of four different donors with TRIZOL
reagent according to the manufacturers’ instructions.
Samples and human brain RNA (Invitrogen AM6050)
were transcribed to cDNA (SuperScript First-Strand
Synthesis System for RT-PCR, Clontech Laboratories).
Semi-quantitative real-time PCR was done with the
SYBR®Advantage®qPCR Premix (Clontech Laboratories)
using samples and standard concentrations of human
brain cDNA in duplicates. The used primer pairs
(Microsynth) and 7300 Applied Biosystems Cycler pro-
gramming can be viewed in the additional files [Addi-
tional file 2]. Calculations were performed using the
standard curve. Statistical analysis (means, standard
deviations) was done using GraphPad Prism 5.
4.4. SDS-PAGE and Western Blot
Protein content of the respective immune cell lysates
obtained from three different donors was determined
using the BCA method (Sigma). The human brain tissue
lysate was purchased from Abcam (ab29466). SDS-PAGE
and Western Blot were performed with the NuPAGE
system (Invitrogen) and the ECL Advance Kit (GE
Healthcare), both used according to the manufacturers’
instructions. After blocking, primary antibodies were
added: goat anti-Nogo-A (Santa Cruz sc-11032) and rab-
bit anti-Nogo A/B/C (Chemicon AB5666P). Membranes
were washed extensively, followed by incubation with the
secondary antibody: anti-goat HRP (Santa Cruz sc-2354)
or anti-rabbit HRP (GE Healthcare NA934). After wash-
ing, detection/exposure took place using films by GE
Healthcare and the developer/fixer by Kodak. Successful
quenching experiments with target peptides were per-
formed (data not shown).
4.5. Cell culture and indirect immunofluorescence
staining
PBMC of six different donors were individually resus-
pended in RPMI 1640 with Glutamax (Invitrogen) and
cultured in cell culture plates (TPP) or on pre-coated
Collagen I culture slides (BD Bioscience). Monocytes
were allowed to adhere for 1 hour (37°C, 5% CO2), fol-
lowed by the removal of non-adherent cells. Adherent
cells were kept in culture for 8-10 days to generate
mature monocyte-derived macrophages. The media used
were CellGro DC medium (CellGenix) for cultures in
cell culture plates (conventional fluorescence micro-
scopy) or 5% autologous heat-inactivated serum in
RPMI1640 with Glutamax containing antibiotics (Peni-
cillin-Streptomycin, Invitrogen) for cultures on slides
(confocal scanning microscopy). Cells for actin stainings
were treated with 100 ng/ml Interferon-gamma (Invitro-
gen) for 48 h before fixation to enhance the actin stain-
ing. Cells were fixed/permeabilized with either 100%
methanol (-20°C) or 4% paraformaldehyde (37°C)/0.2%
CHAPS (Sigma). After blocking (5% normal goat serum,
1% bovine serum albumin, 2 μg/ml human immunoglo-
bulin G in PBS, all by Sigma), the primary antibodies
were added [see Additional file 3]. After washing, the
secondary antibodies (Invitrogen) or TRITC-labeled
phalloidin (Millipore) were added: anti-mouse Alexa
Fluor 546, anti-rabbit Alexa Fluor 488.
Cells were analyzed by conventional fluorescence
microscopy using a DMI 4000B inverse microscope and
Application Suite V3.1 by Leica (Figure 2, Figure 3 and
Additional file 1).
Cells were analyzed by confocal laser scanning micro-
scopy using an UltraVIEW RS (Perkin Elmer) mounted
on an Olympus IX-70 inverse microscope. Images were
acquired using the UltraVIEW RS software (Perkin
Elmer) in combination with a 100x oil immersion objec-
tive with a numerical aperture of 1.4. Excitation wave-
lenghts used were 488 nm (green) and 568 nm (red).
Shown are z-stacks of 0.5 μm thickness. All images were
edited using Adobe Photoshop CS3. Manipulations did
not change the data content.
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Additional material
Additional file 1: Indirect immunofluorescence staining for Nogo-B
in monocyte-derived macrophage cultures of different donors.
Images of individual mature monocyte-derived macrophage cultures
obtained from a total of six different healthy human donors showing
comparable Nogo-B staining patterns and distributions: cells show
elongate-punctate, peripheral Nogo-B staining patterns as well as Nogo-B
accumulations in membrane protrusions and at the trailing end of
migrating macrophages. (a) Overview images, each from two separate
donors. (b) Detail images, using anti-rabbit Alexa Fluor 546 antibodies
(Invitrogen) for detection; images are acquired from stainings of
independent cultures obtained from three different donors. (c) Detail
images, using anti-rabbit Alexa Fluor 488 antibodies (Invitrogen) for
detection; images are acquired from stainings of independent cultures
obtained from five different donors; scale bar is 20 μm; all images were
acquired by conventional fluorescence microscopy using a DMI 4000B
microscope by Leica with either Application Suite V3.1 by Leica or a
mounted Canon Power Shot A620 digital camera.
Additional file 2: Primers used for detection of Nogo splicing
forms/housekeeping genes. Table of primer pairs used for real-time
PCR and GenBank transcript accession number of human Nogo-A
(RTN4A), Nogo-B (RTN4B), Nogo-C (RTN4C) as well as ACTB (beta actin)
and TBP (TATA box binding protein), serving as housekeeping genes for
analysis. The thermo cycler was programmed as follows: 2 min at 95°C,
followed by 40 cycles (10 sec at 95°C and 31 sec at 68°C). As quality
control, a melting curve was added after each run. File can be viewed in
landscape format.
Additional file 3: Primary antibodies used in indirect
immunofluorescence co-labeling. Antibodies used in co-labeling of
Nogo-B and Vinculin (focal/podosomal adhesion sites), RhoA and Rac1
(cytoskeletal structures), Tubulin (tubulin network), Calnexin (endoplasmic
reticulum) and GM-130 (Golgi apparatus) in monocyte-derived
macrophages.
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